|  | Total | |
---|---|---|---|
 |  | Frequency | Percentage |
 | Significant improvement | 2019 | 58.97% |
 | Small improvement | 1229 | 35.89% |
Treatment effect | No improvement | 147 | 4.29% |
 | Small deterioration | 17 | 0.50% |
 | Significant deterioration | 12 | 0.35% |
 | Total | 3424 | 100.00% |
 | Not serious | 975 | 28.48% |
Severity of disease | General | 1770 | 51.69% |
 | Serious | 531 | 15.51% |
 | Unknown | 148 | 4.32% |
 | Total | 3424 | 100.00% |
 | Emergency and serious disease | 539 | 15.74% |
Stage of the disease | Non-emergency disease at initial stage | 2026 | 59.17% |
 | Non-emergency disease at medium stage | 526 | 15.36% |
 | Non-emergency stable disease at late stage | 333 | 9.73% |
 | Total | 3424 | 100.00% |
 | [0,108) | 856 | 25.00% |
Medical expense (Â¥) | [108,258) | 856 | 25.00% |
 | [258,800) | 856 | 25.00% |
 | [800- | 856 | 25.00% |
 | Total | 3424 | 100.00% |
 | 100% | 238 | 6.95% |
 | (70%, 100%) | 591 | 17.26% |
Reimbursement percentage of medical costs | [40%, 70%) | 500 | 14.60% |
 | [20%, 40%) | 201 | 5.87% |
 | (0%, 20%) | 106 | 3.10% |
 | 0% | 1788 | 52.22% |
 | Total | 3424 | 100.00% |